MANCIA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 80.654
EU - Europa 32.780
AS - Asia 21.106
SA - Sud America 1.481
AF - Africa 205
Continente sconosciuto - Info sul continente non disponibili 93
OC - Oceania 76
Totale 136.395
Nazione #
US - Stati Uniti d'America 79.288
SG - Singapore 8.086
CN - Cina 5.823
SE - Svezia 5.374
IE - Irlanda 5.322
HK - Hong Kong 4.978
DE - Germania 4.713
RU - Federazione Russa 4.629
IT - Italia 4.232
UA - Ucraina 3.456
GB - Regno Unito 1.756
BR - Brasile 1.227
CA - Canada 1.207
FI - Finlandia 883
VN - Vietnam 697
AT - Austria 548
FR - Francia 539
IN - India 348
NL - Olanda 305
TR - Turchia 301
DK - Danimarca 197
ID - Indonesia 172
BE - Belgio 164
CZ - Repubblica Ceca 108
JP - Giappone 104
MX - Messico 93
IR - Iran 84
PL - Polonia 81
EU - Europa 75
KR - Corea 67
ES - Italia 61
AU - Australia 60
AR - Argentina 55
RO - Romania 54
CH - Svizzera 50
GR - Grecia 48
PT - Portogallo 48
IQ - Iraq 40
TW - Taiwan 40
PE - Perù 39
VE - Venezuela 39
CO - Colombia 38
EC - Ecuador 38
BG - Bulgaria 35
ZA - Sudafrica 33
UZ - Uzbekistan 31
AE - Emirati Arabi Uniti 30
BD - Bangladesh 30
CL - Cile 28
PH - Filippine 27
PK - Pakistan 27
MA - Marocco 25
EG - Egitto 24
TN - Tunisia 23
IL - Israele 21
TH - Thailandia 20
KZ - Kazakistan 19
MY - Malesia 19
SK - Slovacchia (Repubblica Slovacca) 19
KE - Kenya 18
AZ - Azerbaigian 17
HU - Ungheria 17
LK - Sri Lanka 16
LV - Lettonia 16
NZ - Nuova Zelanda 16
NG - Nigeria 15
NO - Norvegia 15
AL - Albania 14
BY - Bielorussia 14
LT - Lituania 14
MU - Mauritius 14
SA - Arabia Saudita 13
A2 - ???statistics.table.value.countryCode.A2??? 12
AM - Armenia 12
RS - Serbia 12
DO - Repubblica Dominicana 11
JM - Giamaica 11
NP - Nepal 11
DZ - Algeria 10
MD - Moldavia 10
CM - Camerun 9
PA - Panama 9
EE - Estonia 8
GE - Georgia 8
MK - Macedonia 8
BB - Barbados 7
HR - Croazia 7
KG - Kirghizistan 7
LB - Libano 7
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
JO - Giordania 6
LA - Repubblica Popolare Democratica del Laos 6
PY - Paraguay 6
SI - Slovenia 6
HN - Honduras 5
KH - Cambogia 5
OM - Oman 5
PS - Palestinian Territory 5
XK - ???statistics.table.value.countryCode.XK??? 5
Totale 136.297
Città #
Ann Arbor 13.090
Woodbridge 8.063
Fairfield 7.993
Houston 5.663
Singapore 5.304
Dublin 5.087
Hong Kong 4.949
Chandler 4.642
Ashburn 3.998
Jacksonville 3.868
Wilmington 3.403
Frankfurt am Main 3.088
Seattle 3.088
Dearborn 2.674
Cambridge 2.610
New York 2.298
Princeton 2.041
Santa Clara 1.804
Milan 1.265
Lawrence 968
Altamura 954
Nanjing 940
Beijing 872
Shanghai 629
San Diego 590
Lachine 581
Hangzhou 479
Vienna 473
Dong Ket 356
Boardman 349
Andover 320
Nanchang 314
Guangzhou 289
Council Bluffs 286
Shenyang 280
Ottawa 273
Hebei 260
Helsinki 252
Toronto 244
Falls Church 243
Tianjin 189
Jiaxing 185
Norwalk 185
Changsha 181
Los Angeles 172
London 169
Brussels 138
São Paulo 132
Fremont 130
Mountain View 121
Nuremberg 120
Jinan 117
Jakarta 115
Huizen 99
Rome 98
Philadelphia 95
Kunming 93
Lissone 93
Munich 84
Zhengzhou 84
San Mateo 80
Redmond 79
Brno 78
Ningbo 74
Chicago 71
Moscow 69
Nürnberg 68
Dallas 67
Hefei 64
Auburn Hills 49
Pune 46
Detroit 45
Leawood 45
Saint Petersburg 44
Belo Horizonte 43
Monza 43
Washington 43
University Park 41
Lappeenranta 40
Taizhou 39
Edmonton 38
Mumbai 37
Sacramento 37
Groningen 35
Fuzhou 33
Hounslow 33
Amsterdam 32
Kraków 32
Phoenix 32
Bologna 31
Kilburn 31
Perugia 31
Monmouth Junction 30
Chengdu 29
Rio de Janeiro 29
Brasília 27
Kiev 27
Assago 26
Cinisello Balsamo 26
Prescot 26
Totale 99.230
Nome #
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 764
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 435
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 361
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 356
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 352
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 332
Good adherence to therapy with statins reduces the risk of adverse clinical outcomes even among very elderly. Evidence from an Italian real-life investigation 323
Relationship between arterial distensibility and coronary atherosclerosis in angina patients 322
Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study 310
Heart rate as a sympathetic marker during acute adrenergic challenge 309
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 304
Erratum: Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study [High Blood Press Cardiovasc Prev, DOI 10.1007/s40292-015-0121-4] 302
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 295
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 291
Early cardiac and vascular structural changes in subjects with parental hypertension 284
Calcium antagonists and neural control of circulation in essential hypertension 276
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 275
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension 267
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 265
Cardiopulmonary receptor regulation of renin release 263
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 258
2013 ESH/ESC practice guidelines for the management of arterial hypertension 258
Early alterations in left ventricular diastolic function in normotensive diabetic patients 257
Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study 255
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 254
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 254
Home blood pressure telemonitoring improves hypertension control in general practice. the TeleBPCare study 248
European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring 246
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 245
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 244
Studio della distensibilita arteriosa nell'uomo. Quali i meccanismi di modulazione, come varia in condizioni patologiche ed effetto della terapia [Study of arterial distensibility in man. Modulating mechanisms, pathological conditions and effects of treatment] 240
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 240
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 239
External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data 236
Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009 230
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 229
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 228
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans 228
Different effects of antihypertensive treatment on office and ambulatory blood pressure: Ameta-analysis 227
Better compliance to antihypertensive medications reduces cardiovascular risk 226
Differing associations for sport versus occupational physical activity and cardiovascular risk 226
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 224
Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy 222
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 221
Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: real-world evidence from Italy 221
Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy 221
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 220
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 220
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 217
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 214
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 214
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 213
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 213
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period 212
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 211
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 211
Modification of arterial baroreflexes by captopril in essential hypertension 211
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 210
High altitude exposure of three weeks duration increases lung diffusing capacity in humans 209
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 208
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 208
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 206
Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors 205
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 205
Two-Drug Combinations as First-Step Antihypertensive Treatment 205
2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension 204
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension 204
Early impairment of large artery structure and function in Type I diabetes mellitus 204
Control of blood pressure by carotid sinus baroreceptors in human beings 201
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 200
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 199
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 199
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms 198
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 198
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 197
The Pamela study: main findings and perspectives 197
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 197
Treatment of hypertension: The ESH/ESC guidelines recommendations 197
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 197
Acute effect of high-fat meal on endothelial function in moderately dyslipidemic subjects 196
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 196
Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic parents 196
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction 196
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 195
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 195
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 195
Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments 194
Cardiogenic reflexes and left ventricular hypertrophy 194
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 194
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension 194
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 193
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 193
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 192
Dynamic adaptation of cardiac baroreflex sensitivity to prolonged exposure to microgravity: data from 16-day spaceflight 192
Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class 192
First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension 192
Management of antihypertensive drugs in three European countries 191
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 191
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 191
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 190
Totale 23.729
Categoria #
all - tutte 559.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 559.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.881 0 0 0 0 0 0 0 0 0 988 1.344 549
2020/202115.971 1.123 843 1.619 1.706 1.136 1.240 1.621 1.319 1.296 1.758 805 1.505
2021/202213.869 817 1.329 1.895 1.173 969 907 796 768 760 895 1.332 2.228
2022/202318.889 2.547 5.584 1.589 1.722 1.179 2.916 156 966 1.258 129 515 328
2023/202416.483 598 752 572 587 2.688 3.830 3.079 479 1.823 305 239 1.531
2024/202523.399 2.449 5.075 1.488 1.678 3.522 938 2.227 1.450 4.223 349 0 0
Totale 140.710